Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Ipsen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ipsen's 2013 oncology sales performance.

Ipsen S.A.

European Commission approves Opdivo plus Cambometyx for advanced kidney cancer

European Commission approves Opdivo plus Cambometyx for advanced kidney cancer The European Commission (EC) has approved a combination of Bristol Myers Squibb’s (BMS) Opdivo with Ipsen’s Cabometyx for the first-line treatment of advanced renal cell carcinoma (RCC) – the ... The EC approval for Opdivo plus tyrosine kinase

Ipsen

By doing this, we strengthened Ipsen’s relevance by stripping it to its core and what matters most – business, patients and people. ... It was obvious that Ipsen have carried out a huge amount of work internally throughout 2019.

AstraZeneca Global Corporate Affairs

- - PMLiVE - PMLiVE

In-House Team of the Year

Until 2019, being seen as ‘relevant’ to key stakeholders was one of Ipsen’s biggest challenges, but we saw this as an opportunity to put the company on the map as ... By doing this, we strengthened Ipsen’s relevance by stripping it to its core

Revenue growth at Ipsen numbs pain of palovarotene calamity

Revenue growth at Ipsen numbs pain of palovarotene calamity Then, just last month, Ipsen said the drug had failed a futility test in its registrational MOVE trial, suggesting it was heading for failure. ... In the near-term, Ipsen’s late-stage R&D beyond palovarotene is focused mainly on line extensions for

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...

Latest intelligence

Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
How scientific storytelling can help Pharma cut through the noise
Rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut...